These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32775420)

  • 1. Elevated miRNA Inversely Correlates with
    Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
    Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNA in inflammatory bowel disease.
    Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
    J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
    Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
    Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition.
    Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D
    J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
    Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
    Front Immunol; 2019; 10():2449. PubMed ID: 31824476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G
    Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
    Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
    Valmiki S; Ahuja V; Paul J
    World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
    Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
    World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
    Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
    Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis.
    Ranjha R; Aggarwal S; Bopanna S; Ahuja V; Paul J
    PLoS One; 2015; 10(11):e0142869. PubMed ID: 26569605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
    Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
    Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J
    J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
    Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
    Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.